
Basic data
- NeuroDevelopment
- Salud
AEI
Biomarker-driven Adaptive Virtual Reality Stimulation for ASD Interventions
AEI
The overall goal of the ADAPTEA project is to design, develop and test a biomarker-based adaptive virtual reality (BAVR) system for ASD interventions using a computational psychiatry paradigm based on psychophysiological and behavioral biomarkers while exposed to replications of complex social conditions using virtual reality interfaces. The central hypothesis of this project states that biomarker-driven adaptive virtual reality (BAVR) stimulation may be a useful clinical tool for ASD interventions. This new paradigm proposed by ADAPTEA not only has the potential to generate impactful contributions in clinical areas related to ASD, but also provides remarkable methodological contributions. Although some of the tools (VR, biosignal processing, machine learning) to be used in ADAPTEA are known and well established, the interest of the project is not phenomenological but methodological. The proposed tool (BAVR), guided by a paradigm of computational psychiatry based on Bayesian theories of autism, constitutes a radical change in the treatment of ASD and will face complex technical and methodological challenges extremely relevant to the area of neurodevelopmental disorders in general, and more specifically, to ASD.
The overall goal of the ADAPTEA project is to design, develop and test a biomarker-based adaptive virtual reality (BAVR) system for ASD interventions using a computational psychiatry paradigm based on psychophysiological and behavioral biomarkers while exposed to replications of complex social conditions using virtual reality interfaces. The central hypothesis of this project states that biomarker-driven adaptive virtual reality (BAVR) stimulation may be a useful clinical tool for ASD interventions. This new paradigm proposed by ADAPTEA not only has the potential to generate impactful contributions in clinical areas related to ASD, but also provides remarkable methodological contributions. Although some of the tools (VR, biosignal processing, machine learning) to be used in ADAPTEA are known and well established, the interest of the project is not phenomenological but methodological. The proposed tool (BAVR), guided by a paradigm of computational psychiatry based on Bayesian theories of autism, constitutes a radical change in the treatment of ASD and will face complex technical and methodological challenges extremely relevant to the area of neurodevelopmental disorders in general, and more specifically, to ASD.
Mariano L. Alcañiz Raya
Project coordinator
upv